| pubmed-article:18326747 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:18326747 | lifeskim:mentions | umls-concept:C0026809 | lld:lifeskim |
| pubmed-article:18326747 | lifeskim:mentions | umls-concept:C0025663 | lld:lifeskim |
| pubmed-article:18326747 | lifeskim:mentions | umls-concept:C1801960 | lld:lifeskim |
| pubmed-article:18326747 | lifeskim:mentions | umls-concept:C0600518 | lld:lifeskim |
| pubmed-article:18326747 | lifeskim:mentions | umls-concept:C0003250 | lld:lifeskim |
| pubmed-article:18326747 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:18326747 | lifeskim:mentions | umls-concept:C0392747 | lld:lifeskim |
| pubmed-article:18326747 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:18326747 | pubmed:dateCreated | 2008-3-10 | lld:pubmed |
| pubmed-article:18326747 | pubmed:abstractText | The purpose of this study was to evaluate different methods of detecting and quantifying experimentally induced choroidal neovascularization (CNV) and vascular changes induced on CNV by an anti-VEGF-A monoclonal antibody. | lld:pubmed |
| pubmed-article:18326747 | pubmed:language | eng | lld:pubmed |
| pubmed-article:18326747 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18326747 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:18326747 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18326747 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18326747 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18326747 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18326747 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18326747 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18326747 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18326747 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18326747 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18326747 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:18326747 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:18326747 | pubmed:issn | 0146-0404 | lld:pubmed |
| pubmed-article:18326747 | pubmed:author | pubmed-author:FerraraNapole... | lld:pubmed |
| pubmed-article:18326747 | pubmed:author | pubmed-author:FuhGermaineG | lld:pubmed |
| pubmed-article:18326747 | pubmed:author | pubmed-author:YeWeilanW | lld:pubmed |
| pubmed-article:18326747 | pubmed:author | pubmed-author:LeeWyne PWP | lld:pubmed |
| pubmed-article:18326747 | pubmed:author | pubmed-author:CampaClaudioC | lld:pubmed |
| pubmed-article:18326747 | pubmed:author | pubmed-author:KasmanIanI | lld:pubmed |
| pubmed-article:18326747 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:18326747 | pubmed:volume | 49 | lld:pubmed |
| pubmed-article:18326747 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:18326747 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:18326747 | pubmed:pagination | 1178-83 | lld:pubmed |
| pubmed-article:18326747 | pubmed:meshHeading | pubmed-meshheading:18326747... | lld:pubmed |
| pubmed-article:18326747 | pubmed:meshHeading | pubmed-meshheading:18326747... | lld:pubmed |
| pubmed-article:18326747 | pubmed:meshHeading | pubmed-meshheading:18326747... | lld:pubmed |
| pubmed-article:18326747 | pubmed:meshHeading | pubmed-meshheading:18326747... | lld:pubmed |
| pubmed-article:18326747 | pubmed:meshHeading | pubmed-meshheading:18326747... | lld:pubmed |
| pubmed-article:18326747 | pubmed:meshHeading | pubmed-meshheading:18326747... | lld:pubmed |
| pubmed-article:18326747 | pubmed:meshHeading | pubmed-meshheading:18326747... | lld:pubmed |
| pubmed-article:18326747 | pubmed:meshHeading | pubmed-meshheading:18326747... | lld:pubmed |
| pubmed-article:18326747 | pubmed:meshHeading | pubmed-meshheading:18326747... | lld:pubmed |
| pubmed-article:18326747 | pubmed:meshHeading | pubmed-meshheading:18326747... | lld:pubmed |
| pubmed-article:18326747 | pubmed:meshHeading | pubmed-meshheading:18326747... | lld:pubmed |
| pubmed-article:18326747 | pubmed:meshHeading | pubmed-meshheading:18326747... | lld:pubmed |
| pubmed-article:18326747 | pubmed:meshHeading | pubmed-meshheading:18326747... | lld:pubmed |
| pubmed-article:18326747 | pubmed:meshHeading | pubmed-meshheading:18326747... | lld:pubmed |
| pubmed-article:18326747 | pubmed:meshHeading | pubmed-meshheading:18326747... | lld:pubmed |
| pubmed-article:18326747 | pubmed:meshHeading | pubmed-meshheading:18326747... | lld:pubmed |
| pubmed-article:18326747 | pubmed:meshHeading | pubmed-meshheading:18326747... | lld:pubmed |
| pubmed-article:18326747 | pubmed:year | 2008 | lld:pubmed |
| pubmed-article:18326747 | pubmed:articleTitle | Effects of an anti-VEGF-A monoclonal antibody on laser-induced choroidal neovascularization in mice: optimizing methods to quantify vascular changes. | lld:pubmed |
| pubmed-article:18326747 | pubmed:affiliation | Genentech, Inc., South San Francisco, California, USA. claudio.campa@yahoo.com | lld:pubmed |
| pubmed-article:18326747 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:18326747 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:18326747 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18326747 | lld:pubmed |
